T he sequencing artifacts discussed in Chen et al. (1) have been described in publications from The Cancer Genome Atlas (TCGA) and other cancer genome projects (2) (3) (4) . Accordingly, effective mitigation strategies have long been implemented, including software pipelines and improved library preparation methods, as described in Costello et al. (2) . Thus, findings described in TCGA publications (5) (6) (7) (8) (9) were not affected by oxidative damage, as suggested by Chen et al. The authors do raise general awareness of sequencing artifacts, which include machine errors (2) , DNA oxidation (2-4), and DNA cross-linking (in clinically used formalin-fixed tissues) (10) among others; however, their paper contains several errors that led to incorrect conclusions. The errors affect the following: i) Estimation of oxidative damage levels: Although their reported oxidative damage (8-oxo-G) metric, GIV G_T , is essentially equivalent to an earlier reported metric, oxoQ (2) (3) (4) 11) , their software implementation is limited by using reads aligned only to the forward strand and biased by filtering out low-quality bases. OxoQ was designed to be interpreted as a (Phred-like) base quality score. As such, oxoQ can be compared to typical levels of sequencing errors, which for most Illumina sequencing protocols is roughly at the level of Q~30 (i.e., an error rate of 1 per 1000 bases). We initially noticed a poor agreement between the oxoQ and GIV G_T metrics for damaged samples (oxoQ < 30; Fig. 1A ), whereas scores were consistent for samples with low levels of DNA damage. Examining the methods of Chen et al., we found that the authors' code with default parameters applied a high base quality threshold (Q > 30) and removed sites where total coverage exceeds 100×, which discarded the bulk of the data for the most damaged samples (Fig. 1, C to F) . Adjusting the filtering criteria to include bases with Q > 20 and to allow sites with depth above 100× restored concordance between GIV G_T and oxoQ scores (Fig. 1B) .
ii) Claim of no context specificity of 8-oxo-G damage: The authors' conclusion that they "did not observe nucleotide context specificity" of 8-oxoG damage (1) is a consequence of their filtering out most of the supporting data, as described above. Sequence context specificity is a key feature of 8-oxo-G damage (12) , can affect mutational signature analysis, and can be visualized using "Lego" plots (Fig. 1, D and E) . These plots show the error rate of each type of base substitution in its three-base sequence context (2) . The damaged bases reported by Chen et al.'s script (Fig. 1D) have a severely distorted error profile inconsistent with the previously reported (12) 8-oxo-G damage pattern (Fig. 1E , C > A errors in the Lego plot with a clear peak at the sequence context CCG > CAG), whereas the corrected GIV G_T script [and the previous implementation in (2)] results in a distribution of errors (Fig. 1E ) consistent with 8-oxo-G damage. Thus, 8-oxo-G damage does in fact have a sequence context, which the authors apparently missed as a result of their filtering strategy.
iii) Interpretation of 8-oxo-G damage levels: The authors state that "73% of the TCGA sequencing runs showed extensive damage, with a GIV G_T > 2." A GIV G_T metric of 2 indicates that the G > T error rate in the 8-oxo-G mode is twice the error rate of the non-8-oxo-G mode (background rate for G > T errors). Even if the 8-oxo-G artifacts are twice the context-specific background level (i.e., GIV G_T = 2), this corresponds to only a 5 to 10% increase in the overall base-level error rate (summed over all sequence contexts; Fig. 2 , A to C), which is less than the intersample variability of error rates at a fixed oxoQ. A 5% increase in the base-level error rate results in a minor, if any, increase in false-positive mutation calls (Fig. 2, E and F) , because calling algorithms are designed to handle typical levels of sequencing error. Only at GIV G_T ≳ 5 (equivalent to oxoQ ≲ 35) do the additional errors from 8-oxo-G become comparable to the sum of all other errors and have an adverse impact on variant calling. The vast majority of samples in TCGA exhibit only minor 8-oxo-G damage that has minimal impact on mutation calling. Consequently, the claim that 73% of TCGA sequencing runs have extensive damage is misleading. iv) Estimation of the false positive rate (FPR) of mutation calling: The authors define an FPR metric, which suggests that mutation calls for many samples in public databases contain >50% falsely detected somatic variants due to sequencing artifacts (Fig. 2D) . However, their metric does not reflect the actual somatic mutations used for analyses in (3-10) and other TCGA publications [e.g., a recent reanalysis of TCGA data (13)], but instead represents candidate variants supported by as few as two nonreference reads [not considered as somatic variants by most mutation callers (14) ]. Moreover, the mathematical definition of their FPR metric is neither a FPR nor a false discovery rate (FDR), which is highlighted by the fact that it can range between -1 and 1 (and not between 0 and 1). Therefore, Chen et al. incorrectly concluded that the FPR exceeds 0.5 in samples that have a low level of DNA damage with nearly no damage-induced false-positive mutation calls (Fig. 2, D to G) . v) Finally, Chen et al. overlook publications describing 8-oxo-G damage (2-10) that TCGA and other projects have mitigated with laboratory protocols and software filtering strategies when sequencing library regeneration was impractical (Fig. 2, F and G) . Moreover, they claim that "recent submissions to TCGA (November to December 2015) displayed similar G-to-T imbalances" but mistakenly interpreted the time that the data repository was last updated as the time of sequencing data generation (repository updates occurred periodically for unrelated issues). The actual dates of generating the sequencing data should be obtained from the sequencing metadata. In fact, most TCGA samples sequenced after October 2012 had low 8-oxo-G damage due to improved library preparation [as described in (2)].
In conclusion, we disagree with the assessment of Chen et al. regarding the quality of published cancer genome projects. Raw sequencing data inherently contain errors; therefore, to avoid misinterpreting the data, it is important that researchers use established procedures and carefully curated datasets in downstream analyses.
